Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
D&P Bio-tX is a regenerative medicine company based in San Diego, California, focused on developing "off-the-shelf" implantable medical devices that regenerate organs. The company's core technology, the Bio-tX platform, utilizes a combination of biodegradable scaffolds and autologous stem cells to facilitate the repair of damaged or missing tissues. Their primary focus is on esophageal regeneration, targeting conditions like esophageal atresia in infants and esophageal cancer in adults. By integrating tissue engineering with advanced materials, D&P Bio-tX aims to eliminate the need for complex surgeries like gastric pull-ups. The company has received support from prestigious organizations including Y Combinator and the National Institutes of Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on D&P Bio-tX.